Xia Cheng Selected Research

Coloring Agents (Dyes)

12/2020	Synthesis, characterization and optimization of in vitro properties of NIR-fluorescent cyclic α-MSH peptides for melanoma imaging.
1/2020	Probing two PESIN-indocyanine-dye-conjugates: significance of the used fluorophore.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xia Cheng Research Topics

Disease

10	Neoplasms (Cancer) 05/2022 - 01/2005
5	Carcinoma (Carcinomatosis) 12/2020 - 01/2005
3	Melanoma (Melanoma, Malignant) 06/2021 - 01/2014
2	Adenocarcinoma 05/2022 - 12/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 01/2015
2	Breast Neoplasms (Breast Cancer) 11/2019 - 08/2014
2	Stomach Neoplasms (Stomach Cancer) 08/2013 - 05/2010
2	Flatulence 01/2013 - 05/2010
2	Rectal Neoplasms (Rectal Cancer) 05/2011 - 04/2006
1	Sepsis (Septicemia) 09/2022
1	Lung Injury 09/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022
1	Myocardial Infarction 01/2022
1	Fibrosis (Cirrhosis) 08/2021
1	Lymphatic Metastasis 06/2021
1	Idiopathic Pulmonary Fibrosis 05/2021
1	Colorectal Neoplasms (Colorectal Cancer) 03/2021
1	Anthrax 01/2021
1	Inflammation (Inflammations) 06/2014
1	Hemorrhage 04/2012
1	Neoplasm Metastasis (Metastasis) 05/2011
1	Intraoperative Complications 05/2010
1	Pancreatitis 09/2008
1	Pain (Aches) 09/2008
1	Experimental Melanoma 10/2007
1	Body Weight (Weight, Body) 10/2007

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 06/2021 - 01/2020
2	CateninsIBA 09/2022 - 08/2021
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2021
2	Metal-Organic FrameworksIBA 01/2022 - 01/2021
2	Type 1 Melanocortin ReceptorIBA 06/2021 - 12/2020
2	CarbonIBA 01/2021 - 05/2011
2	Coloring Agents (Dyes)IBA 12/2020 - 01/2020
2	Keratins (Keratin)IBA 12/2020 - 05/2011
2	isogambogenic acidIBA 04/2020 - 01/2015
2	C-Reactive ProteinIBA 07/2009 - 09/2008
1	CREB-Binding ProteinIBA 09/2022
1	ICG 001IBA 09/2022
1	Interleukin-10 (Interleukin 10)IBA 09/2022
1	Immune Checkpoint InhibitorsIBA 05/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 08/2021
1	Proteins (Proteins, Gene)FDA Link 08/2021
1	IntegrinsIBA 06/2021
1	LigandsIBA 06/2021
1	RNA IIBA 03/2021
1	Long Noncoding RNAIBA 03/2021
1	Lanthanoid Series Elements (Lanthanides)IBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021
1	Molecular Probes (Molecular Probe)IBA 12/2020
1	Melanocyte-Stimulating Hormones (MSH)IBA 12/2020
1	villinIBA 12/2020
1	BombesinIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Tamoxifen FDA LinkGeneric 11/2019
1	icariinIBA 11/2019
1	Ethylene Glycol (Monoethylene Glycol)IBA 11/2015
1	MicellesIBA 11/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014
1	ORALIT (ORS)IBA 08/2014
1	gambogic acidIBA 06/2014
1	AlginatesIBA 01/2014
1	Caspase 3 (Caspase-3)IBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	3- (3- amino- 4- methoxyphenyl)- 1- (5- methoxy- 2,2- dimethyl- 2H- chromen- 8-yl)prop-2-en-1-oneIBA 01/2014
1	millepachineIBA 01/2014
1	SuspensionsIBA 05/2011
1	2,5-dichloro-4-bromophenol (B 2)IBA 05/2010
1	Immunoglobulins (Immunoglobulin)IBA 07/2009
1	Therapeutic UsesIBA 09/2008
1	VaccinesIBA 10/2007
1	AntibodiesIBA 01/2005

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2020 - 11/2015
2	Immunotherapy 05/2022 - 01/2005
2	Gastrectomy 08/2013 - 05/2010
2	Operative Time 01/2013 - 04/2012
1	Punctures 09/2022
1	Ligation 09/2022
1	Therapeutics 05/2021
1	Neoadjuvant Therapy 12/2020
1	Lymph Node Excision (Lymph Node Dissection) 04/2012
1	Colectomy 04/2012
1	Endoscopes 05/2011
1	Operative Surgical Procedures 05/2010
1	Length of Stay 05/2010
1	Conversion to Open Surgery 05/2010
1	Aftercare (After-Treatment) 09/2008
1	Laparoscopic Cholecystectomy 04/2006